OCUL - 6.49 Pre-market now at 7.72/7.84 Ocular Therapeutix(TM) Submits Amendment to Potentially Extend Review for DEXTENZA(TM) New Drug Application (NDA) http://stockcharts.com/c-sc/sc?s=OCUL&p=D&b=5&g=0&i=t82057521133&r=1499776929940 http://stockcharts.com/c-sc/sc?s=OCUL&p=W&b=5&g=0&i=t24373350955&r=1499776951920